Advancing the standard of cancer care and offering patients access to new therapies

Our goal is to offer every patient the option of the latest treatment available for their cancer. To do that, Norton Cancer Institute is participating in approximately 170 clinical trials at any time. These clinical [...]

Study shows low-dose cadmium threshold for testicular ferroptosis in mice

Cadmium, a natural element used for rechargeable batteries and other industrial applications, can induce a novel type of testicular cell death in mice after low-dose exposure, according to a groundbreaking study. Cadmium is known to […]

First successful “valve-in-MAC” transcatheter mitral valve replacement in Louisville region

A multidisciplinary team of interventional cardiologists and a cardiothoracic surgeon performed Louisville’s first successful transcatheter replacement of a native mitral valve this week. The team with Norton Heart & Vascular Institute Structural Heart Program used […]

Clinical trial summary: Venetoclax plus LDAC for adult AML patients at high risk of toxicity

Clinical challenge Acute myeloid leukemia (AML) patients ages 75 and older, and younger adults with comorbidities, are often ineligible to receive standard intensive chemotherapy due to high rates of toxicity and early mortality. As a [...]

Drs. Ramirez and Carrico

Study looks at how to detect RSV in adults

Norton Infectious Diseases Institute has been selected by Pfizer as the only site in United States to study how to effectively detect respiratory syncytial virus (RSV) in adults. “For the most part, RSV attention has [...]

Michael L. Sweeney, M.D., co-authored a review of anti-CD20 monoclonal antibody therapy.

Anti-CD20 monoclonal antibody therapy for relapsing MS in adult patients

Anti-CD20 monoclonal antibody therapy represents a major advance in treating relapsing multiple sclerosis (MS) in adult patients, reducing relapse risk and mitigating disability progression. These monoclonal antibody therapies deplete circulating B cells by targeting CD20, [...]

Reduced-toxicity myeloablative conditioning regimen effective against high-risk pediatric leukemias

A low-toxicity myeloablative conditioning regimen is safe and effective in treating high-risk leukemias, particularly myeloid disease, according to a study recently published in the journal Pediatric Blood & Cancer. Conventional myeloablative conditioning is effective at […]

New guidelines for bone health assessment before elective spinal reconstruction

The Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines for Perioperative Spine: Preoperative Osteoporosis Assessment recently was published in Neurosurgery. To develop these recommendations, the authors performed systematic review of the literature using national [...]

As mental health disorders can be one of the “invisible” symptoms of multiple sclerosis (MS), mental health care can be a part of routine MS care through the regular use of screening tools and an integrated approach to treatment.

Mental health and provider considerations when treating multiple sclerosis

As mental health disorders can be one of the “invisible” symptoms of multiple sclerosis (MS), mental health care can be a part of routine MS care through the regular use of screening tools and an [...]

Get Our Monthly Newsletter

Stay informed on the latest offerings and treatments available at Norton Healthcare by subscribing to our monthly enewsletter.


Make a Referral

Partnering with you in caring for your patients.

Refer a Patient
Are You a Patient?
Provider Spotlight

Andrew D. Doering, M.D.

Andrew D. Doering, M.D., has joined Norton Urogynecology Center, caring for patients with a variety of urinary and pelvic conditions.

Read More

Treating amyloid cardiomyopathy (ATTR-CM) with tafamidis

New treatments are available for patients with transthyretin amyloid cardiomyopathy (ATTR-CM), a rare, underdiagnosed condition that causes faulty proteins to build up in the heart. Untreated, the condition leads to heart failure and death. An […]

Read Full Story

November 2022 Norton Children’s Medical Group New Providers

Desarae Brymer, LCSW Pediatric Behavioral Medicine Andrea P. Roberts, APRN Neonatology Annie Shaughnessy, APRN Pediatrics

Read Full Story

November 2022 Norton Medical Group new providers

Shelbi Basham, APRN Urgent Care Devon Blandford, PA-C Hospital Medicine Julie N. Crawford, APRN Family Medicine Heather Hurst, APRN Urgent Care Lindsay Norton, M.D. Behavioral Medicine Whoy Yurn Shang, APRN Memory and Cognitive Disorders Neurology […]

Read Full Story

Health disparities in cardiology

In a recent continuing medical education presentation, Kelly C. McCants, M.D., executive medical director, Norton Heart & Vascular Institute Advanced Heart Failure & Recovery Program, and executive director, Institute for Health Equity, a Part of […]

Read Full Story

Growing pains are challenging, but diabetes care shouldn’t be part of that stress

Most children who have diabetes get their medical care for their condition from a pediatric endocrinologist. As they get older and approach adulthood, they will transition into adult care. It’s important to discuss the process […]

Read Full Story

Search our entire site.